Skip to content

A study in healthy men to find out how blocking certain transport proteins affects the amount of BI 3000202 in the blood

Status
Not yet recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2026-525549-60-00
Enrollment
16
Registered
2026-07-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Interventions

None listed

Sponsors

Boehringer Ingelheim International GmbH
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
Male
Age
18 Years to 64 Years

Outcome results

None listed

Source: EU CTIS · Data processed: Jul 2, 2026